Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 20 · below the Ichimoku cloud · RSI 40 · MACD above its signal · 4% above its 52-week low
None of the 29 investors followed here reported a position in PFSA in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a PFSA trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 16, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 1.13 per share. | 18.4K | $20.83K |
| Aug 13, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.90 per share. | 3.2K | $2.85K |
| Aug 12, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.89 per share. | 42.4K | $37.66K |
| Aug 11, 2026 | Stover Jack EChief Executive Officer | Conversion of Exercise of derivative security at price 4.28 per share. | 302K | $1.29M |
| Aug 11, 2026 | Knechtel Fred SChief Financial Officer | Conversion of Exercise of derivative security at price 4.28 per share. | 302K | $1.29M |
| Aug 11, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.96 per share. | 5.6K | $5.38K |
| Aug 10, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.97 per share. | 2.3K | $2.21K |
| Aug 9, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.94 per share. | 4K | $3.79K |
| Aug 6, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.94 - 0.95 per share. | 1.3K | $1.24K |
| Aug 5, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.94 per share. | 926 | $873 |
| Aug 3, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.95 - 0.96 per share. | 15.9K | $15.25K |
| Jul 30, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.01 - 1.05 per share. | 9.9K | $10.32K |
| Jul 28, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.01 per share. | 1.3K | $1.32K |
No analyst coverage for this instrument.
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.